AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glytrin-Met Tablet ER

Prescription Icon
Prescription Required

Marketer

Medley Pharmaceuticals

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Glytrin-Met Tablet ER

Metformin/Glyburide Extended-Release tablets manage elevated blood glucose in type 2 diabetes patients by combining two active agents. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially decreasing cardiovascular events like stroke or myocardial infarction. This medication may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician supervision. Effective blood sugar control prevents future health issues. Maintaining the recommended diet and exercise plan is crucial for diabetes management; lifestyle significantly impacts glucose regulation. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, and cephalalgia. Hypoglycemia, particularly if combined with insulin or sulfonylureas, is a potential risk; understand its symptoms and management. This treatment isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Drug interactions are possible; disclose all medications to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your physician will monitor kidney function and blood sugar throughout treatment.

Uses of Glytrin-Met Tablet ER

Managing type 2 diabetes

Major Benefits of Glytrin-Met Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glytrin-Met Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glytrin-Met Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Glytrin-Met Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glytrin-Met Extended-Release tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume this medication with food.

How Glytrin-Met Tablet ER works:

Extended-release Glytrin-Met tablets contain a blend of two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glytrin-Met Tablet ER and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glytrin-Met tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glytrin-Met tablets pose a likely risk during lactation. Available human data indicates potential transfer to breast milk, potentially harming the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Glytrin-Met Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glytrin-Met ER tablets; dosage modification may be necessary. Severe kidney disease contraindicates Glytrin-Met ER tablet use. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Extended-release Glytrin-Met tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Glytrin-Met Tablet ER :

Should you forget a Glytrin-Met Tablet ER dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your normal medication routine. Never take a double dose.

Facts to Know About Glytrin-Met Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glytrin-Met Tablet ER

Glytrin-Met ER tablets are safe when used as prescribed. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Glytrin-Met ER tablets rarely cause hypoglycemia independently, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available source of glucose, such as glucose tablets, honey, or fruit juice, on hand.
Nausea and vomiting are possible side effects of Glytrin-Met Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always ask your doctor before taking any other medication.
Glytrin-Met Tablet ER is contraindicated in patients allergic to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Glytrin-Met Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect involving elevated blood lactic acid. This risk is higher in patients with kidney disease, the elderly, and heavy alcohol users, hence its avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytrin-Met Tablet ER and seek immediate medical attention.
Glytrin-Met ER tablets can cause vitamin B12 deficiency with prolonged use, interfering with its stomach absorption. This deficiency may lead to anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. If you experience these symptoms, consult your doctor; they may recommend B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glytrin-Met Tablet ER
131
MRP 160
18% off